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Summary
During mammalian development, the first two lineages to be
specified are the trophectoderm (TE) and the inner cell mass
(ICM). The Hippo pathway kinases Lats 1 and 2 (Lats1/2) and
the transcriptional coactivator Yap play important roles in
this specification process [1]. In outside cells of the embryo,
Yap is nuclear localized and cooperates with Tead4 to
induce the TE-specifying transcription factor Cdx2. In inside
cells, Lats1/2 phosphorylate Yap and prevent its nuclear
localization. The factors acting upstream of Lats1/2 and
Yap in this context have not been identified. Here, we demon-
strate that the upstream Hippo pathway member Nf2/Merlin
is required for Lats1/2-dependent Yap phosphorylation in
the preimplantation embryo. Injection of dominant-negative
Nf2 mRNA causes Yap mislocalization and ectopic Cdx2
expression, effects that can be rescued by overexpression
of Lats2 kinase. Zygotic Nf2 mutant blastocysts have mild
defects in Yap localization and Cdx2 expression, but these
become much more severe upon removal of both maternal
and zygoticNf2. The inside cells ofmaternal-zygoticmutants
fail to establish a pluripotent ICM and form excess TE,
resulting in peri-implantation lethality. Together, these data
establish a clear role for Nf2 upstream of Yap in the preim-
plantation embryo and demonstrate that Hippo signaling is
essential to segregate the ICM from the TE.
Results and Discussion
Nf2 Is Expressed in the Preimplantation Embryo
Although multiple inputs have been proposed to regulate core
Hippo signaling, the membrane-associated FERM domain
protein neurofibromatosis 2 (Nf2, the ortholog of Drosophila
Merlin) remains the only upstream component shown to be
required for Hippo signaling across a broad range of cell types
[2–6] and to be genetically required for Hippo signaling in vivo
[6, 7]. Given its requirement for Hippo signaling in other cell
types, we reasoned that Nf2 might also play a role upstream
of the Hippo pathway kinases Lats 1 and 2 (Lats1/2) and Yap
in the segregation of trophectoderm (TE) and inner cell mass
(ICM). To determine whether this could be the case, we first
investigated its expression profile during preimplantation
development. We performed qPCR on pools of embryos at
nine different preimplantation stages and found that, while it
could be detected throughout preimplantation development,
Nf2mRNAwas especially abundant prior to the two-cell stage,
suggesting that it is maternally deposited (Figure 1A). To*Correspondence: janet.rossant@sickkids.caexamine the localization of Nf2 protein in the preimplantation
embryo, we cultured embryos that had been injected with
GFP-tagged Nf2mRNA to the morula or early blastocyst stage
and stained them for GFP. Nf2-GFP appeared highly enriched
throughout the plasma membrane in both inside and outside
cells (Figure 1C). Thus, while Nf2 is maternally deposited and
present throughout preimplantation development, its localiza-
tion does not appear to be differentially regulated between
inside and outside cells of the early embryo.
DnNf2 Causes Yap Mislocalization and Cdx2
Misexpression in Inside Cells
We initially assessed Nf2 function by injecting two-cell
embryos with mRNA encoding a dominant-negative form of
the protein (dnNf2) (see Figure S1A available online) [8, 9],
which should inhibit the activity of all Nf2 in the preimplantation
embryo, regardless of its maternal or zygotic origin. As a
positive control, we used mRNA encoding a kinase-dead,
dominant-negative form of Lats2 (kdLats2) [1]. After injection,
embryos were allowed to develop to the morula stage and
stained to examine Yap localization. Consistent with what
has been shown previously [1], the presence of kdLats2
caused Yap to localize to the nuclei of inner cells at the morula
stage, where it is normally cytoplasmic (Figure S2B). A similar
mislocalization of Yap was observed in inside cells of dnNf2-
injected embryos. In contrast, a mixture of mRNAs coding
for the kinase-dead forms of the Hippo kinases Mst1 and
2 (kdMst1/2) [10], thought to phosphorylate and activate
Lats1/2 [11], had no effect on Yap localization. This observa-
tion is consistent with other recent data suggesting that
although they have been considered central to the core Hippo
kinase cascade, Mst1/2 may not be required for Hippo
pathway activation in all cell types [5, 12]. In the context of
the early embryo, another kinase may be required for Lats1/2
activation, or Lats1/2 activation may occur in a phosphoryla-
tion-independent manner.
In addition to inhibiting Nf2 and Lats1/2 function, we also
investigated the consequences of overexpressing these
proteins in the preimplantation embryo. In agreement with pre-
vious work [1], we found that injection of wild-type Lats2
mRNA was sufficient to sequester Yap into the cytoplasm of
outside cells (Figure S2C). In contrast, however, introduction
of even very high concentrations of wild-type Nf2 mRNA had
no discernible effect on Yap localization in outside cells. These
results suggest that, although it is required for Yap phosphor-
ylation in inside cells of the embryo, excess Nf2 alone is not
sufficient to induce Yap phosphorylation in outside cells.
To examine the effects of dnNf2 inmore detail, we generated
mosaic embryos by coinjecting this mRNA, along with GFP
mRNA to act as a lineage tracer, into only one cell at the
two-cell stage (Figure 2A). Consistent with our results in the
morula, we found that Yap localized to the nuclei of inside cells
expressing dnNf2 at the early blastocyst stage (Figures 2B and
2C). This effect was cell autonomous, as Yap remained cyto-
plasmic in inside cells not expressing dnNf2. Notably, despite
causing Yap mislocalization throughout preimplantation
development, dnNf2 expression did not significantly affect
the ability of cells to contribute to inside versus outside cell
populations at the morula, early blastocyst, or late blastocyst
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Figure 1. Nf2 Is Expressed in the Preimplantation
Embryo
(A) qPCR analysis of Nf2 expression in pools of
embryos at nine different preimplantation stages.
(B) Expression of wild-type Nf2 in individual MII
oocytes from wild-type, germline heterozygous
(Nf2+/2), and germline deleted (Nf2flox/flox;
Zp3CreCre/+) females, designated as mNf+/+,
mNf2+/2, and mNf22/2, respectively.
(C) Localization of Nf2-GFP in mosaically injected
embryos at the morula or early blastocyst stage.
Error bars represent SD of biological replicates.
Scale bars represent 25 mm.
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1196stages (Figure S1E), indicating that Nf2 activity and Yap phos-
phorylation are likely downstream of the mechanisms control-
ling positional allocation in the embryo. DnNf2 also caused
ectopic Cdx2 expression in the inside cells of early blastocysts
(Figures 2D and 2E), indicating that the nuclear-localized Yap
in these cells is transcriptionally active.
Levels of phosphorylated Yap in injected blastocysts were
visibly lower in dnNf2-expressing inside cells (Figure S1D),
suggesting that dnNf2 exerts its influence by blocking Lats
kinase phosphorylation of Yap rather than by some parallel
mechanism. To test this, we asked whether expression of
excess Lats kinase could rescue the effects of dnNf2. We first
injected both cells of the embryo at the two-cell stage with
dnNf2 mRNA and then immediately reinjected one of these
two cells with a high level of Lats2mRNA along with GFP (Fig-
ure 2F). Strikingly, this overexpression of Lats2 was able to
rescue the Yap localization defects caused by dnNf2 (Figures
2G and 2H), suggesting that, in agreement with current models
of Hippo signaling [1], Nf2 acts through the Lats kinases to
influence Yap phosphorylation in the preimplantation embryo.
To better understand the relationship between the Lats
kinases and Nf2 in this context, we examined Lats1/2 localiza-
tion by injecting embryos with GFP-tagged Lats2mRNA or by
staining for Lats1. We found that Lats1/2 were apically
enriched at the compacted eight-cell stage and remained
apical in outside cells as development proceeded (Figure S1F).
In contrast, in inside cells Lats1/2 were distributed evenly
throughout the cytoplasm (and weakly at the plasma mem-
brane in the case of Lats1). These differences in Lats1/2 local-
ization between inside and outside cells are in contrast to the
uniform membrane localization of Nf2-GFP (Figure 1C).
Maternal Nf2 Partially Rescues Hippo Signaling
in Zygotic Mutants
Because of its transient nature, injection of dnNf2 mRNA
cannot be used to determine the importance of Nf2 and Hippo
signaling in later blastocyst development and postimplanta-
tion survival. To more fully assess the role of Nf2 in mouse
development, we therefore reexamined the effects of genetic
deletion of Nf2 using a previously generated floxed allele
[13]. Although it has previously been reported that zygotic
Nf2 mutants survive until early postimplantation stages [14],
the earlier development of these embryos has not been inves-
tigated in detail. Thus, we first examined Yap localization in
Nf2 zygotic mutants generated by intercrossing mice hetero-
zygous for a fully Cre-deleted form of the floxed Nf2 allele
(Figure S2A). We found that Yap localization in zygotic mutantblastocysts was mildly affected: a subset of inside cells
showed strongly nuclear Yap, but the majority of inside cells
lacked this clear nuclear accumulation (Figures 3A and 3B).
Similarly, a subset of inside cells in the mutant blastocysts ex-
pressed Cdx2, but most inside cells remained Cdx2 negative
(Figures 3A and 3C). Notably, nuclear Yap often colocalized
with Cdx2 expression in mutant inside cells (Figure 3A). Given
that these embryos implant and survive until later stages [14],
it is likely that this small population of potentially misspecified
cells is excluded from the ICM as the embryo develops.
One explanation for the comparatively mild Yap localization
defects observed in zygotic mutant blastocysts, especially
given our dominant-negative results, could be an incomplete
elimination of Nf2 protein in these embryos. Given the expres-
sion of Nf2 mRNA in the oocyte and early embryo (Figure 1A),
maternally inherited Nf2 could be sufficient to partially
rescue Hippo signaling in zygotic mutants. To test this, we
made use of a female germline-specific Zp3-Cre [15] that
eliminated wild-type Nf2 mRNA from oocytes carrying the
floxed allele (Figure 1B). Nf2flox/flox; Zp3-CreCre/+ females
were crossed with Nf2del/+ males to generate embryos defi-
cient in both maternal and zygotic Nf2 as well as littermates
deficient in maternal Nf2 but zygotically heterozygous (Fig-
ure S2B). When these embryos were allowed to develop to
the blastocyst stage, Yap was strongly nuclear and Cdx2
was ectopically expressed in virtually every inside cell of
maternal-zygotic mutant early blastocysts (Figures 3D–3F).
Notably, Yap and Cdx2 were unaffected in zygotically hetero-
zygous littermates (Figures 2D–2F), indicating that maternal
Nf2 is only important when zygotic transcription has been
affected.
Inside Cells of Maternal-Zygotic Mutant Blastocysts
Resemble the TE and Fail to Form ICM
Although the mislocalized nuclear Yap in inside cells of
maternal-zygotic Nf2 mutants clearly leads to ectopic Cdx2
expression, whether this represents a true switch in cell fate
from ICM to TE remains to be determined. We allowed
maternal-zygotic mutant blastocysts to develop in vitro for
another 24 hr, until the late blastocyst stage, and examined
them for expression of other factors involved in TE specifi-
cation. Because of their normal Yap localization and Cdx2
expression at both the early and late blastocyst stage (Figures
3D, S3A, and S3B), zygotically heterozygous littermates were
used as controls in these experiments. Although often smaller
in volume than littermates, maternal-zygotic mutant late
blastocysts contained the same number of inside and outside
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Figure 2. dnNf2 Causes Yap Mislocalization and Cdx2 Misexpression in Inside Cells
(A) Schematic of dnNf2 mosaic injection experiments shown in (B)–(E).
(B) Yap localization in early blastocysts mosaically expressing GFP or dnNf2 + GFP. Arrowheads indicate inside cells with strongly nuclear Yap. Arrow
indicates an inside cell with weakly nuclear Yap.
(C) Quantification of Yap localization in inside cells of GFP (ten embryos) or dnNf2 + GFP (nine embryos) mosaic early blastocysts.
(D) Cdx2 expression in early blastocysts mosaically expressing GFP or dnNf2 + GFP. Arrowheads indicate inside cells with ectopic Cdx2 expression.
(E) Quantification of Cdx2 expression in inside cells of GFP (11 embryos) or dnNf2 + GFP (nine embryos) mosaic early blastocysts.
(F) Schematic of Lats2 rescue experiment shown in (G) and (H).
(G) Yap localization in early blastocysts ubiquitously expressing dnNf2 andmosaically expressingGFP or Lats2 +GFP. Arrowheads indicate inside cells with
strongly nuclear Yap.
(H) Quantification of Yap localization in inside cells of early blastocysts ubiquitously expressing dnNf2 and mosaically expressing GFP (five embryos) or
Lats2 + GFP (five embryos).
Dashed lines indicate inside cells. Scale bars represent 40 mm. See also Figure S1.
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Figure 3. Maternal Nf2 Partially Rescues Hippo Signaling in Zygotic Mutants
(A) Yap localization and Cdx2 expression in Nf2 zygotic mutants and littermate controls, designated m+z2Nf2 and m+z+Nf2, respectively, at E3.5.
(B andC) Quantification of Yap localization (B) andCdx2 expression (C) in inside cells ofm+z+Nf2 (16 embryos) andm+z2Nf2 (six embryos) early blastocysts
at E3.5.
(D) Yap localization and Cdx2 expression in maternally and zygotically mutant embryos and maternally mutant but zygotically heterozygous littermates,
designated m2z2Nf2 and m2z+Nf2, respectively, at E3.5.
(E and F) Quantification of Yap localization (E) and Cdx2 expression (F) in inside cells of m2z+Nf2 (six embryos) and m2z2Nf2 (nine embryos) early
blastocysts at E3.5.
Arrowheads indicate inside cells with nuclear Yap and ectopic Cdx2. Dashed lines indicate inside cells. Scale bars represent 40 mm. See also Figure S2.
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1198cells (Figure S3C). However, unlike littermates, the inside cells
of maternal-zygotic mutants at this stage ectopically ex-
pressed the TE-specific transcription factors Eomes, Tcfap2c,
and Gata3 [16] (Figures 4A–4C).
Beyond ectopic expression of lineage markers, we also
observed cellular and morphological changes to maternal-
zygotic inside cells that suggested they had adopted a TE-
like phenotype. In littermates at the late blastocyst stage, outer
TE cells formed a normal-looking polarized epithelium with an
outward-facing apical domain labeled by aPKCz and an in-
ward-facing basolateral domain labeled by the Na/K-ATPase
b1 subunit (Atp1b1; Figures 3D and 3E). In apolar inside cells,
aPCKz was cytoplasmically localized and Atp1b1 was entirely
absent. In outside cells of maternal-zygotic mutant late blasto-
cysts the distribution of these two markers was relativelyundisturbed, but in inside cells aPCKz was often aberrantly
localized throughout the plasma membrane with occasional
regions of asymmetric accumulation, while Atp1b1 was
ectopically expressed (Figures 3D and 3E). Additionally, the
tight junction (TJ) marker ZO-1, normally seen in discrete
TJ-associated punctae only in outer cells, could sometimes
be observed forming small punctae or larger aggregations
at the plasma membranes of mutant inside cells (Figure 3F).
Such changes suggest that the inside cells of maternal-
zygotic mutant late blastocysts have begun to take on an
epithelial character, though they lack the positional cues to
establish proper apicobasal polarity. Consistent with the
expanded expression domain of Atp1b1, a factor involved in
fluid accumulation during blastocoel formation [17], many
maternal-zygotic mutant embryos formed additional small
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Figure 4. Inside Cells of Maternal-Zygotic Nf2 Mutant Blastocysts Resemble the TE and Fail to Form ICM
(A–C) Eomes (A), Tcfap2c (B), and Gata3 (C) expression in m2z2Nf2 and m2z+Nf2 late blastocysts flushed at E3.5 and cultured for 24 hr.
(D) aPKCz localization inm2z2Nf2 andm2z+Nf2 late blastocysts. Arrow indicates aPKCz beginning to accumulate at the membrane of a putative primitive
endoderm cell. Arrowheads indicate examples of strongly membrane-enriched aPKCz in mutant inside cells.
(E) Atp1b1 expression in m2z2Nf2 and m2z+Nf2 late blastocysts. Arrowheads indicate examples of Atp1b1 ectopically expressed and localized to the
membrane in mutant inside cells.
(F) ZO-1 localization in m2z2Nf2 and m2z+Nf2 late blastocysts. Arrowheads indicate punctate aggregations of ZO-1 between mutant inside cells.
(G) Oct4 expression in m2z2Nf2 and m2z+Nf2 late blastocysts.
(H) Nanog and Gata6 expression in m2z2Nf2 and m2z+Nf2 late blastocysts. Arrowheads indicate Gata6-positive, Nanog-negative primitive endoderm
cells. Embryos are shown as compound images to demonstrate the complete absence of these markers in the representative m2z2Nf2 blastocyst.
(legend continued on next page)
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1200blastocoel-like cavities among their inside cells (Figures 4A–
4C, 4E, 4G, and S3A).
We next assessed whether, in addition to adopting TE-like
characteristics, these mutant inside cells had entirely lost their
normal ICM identity. We tested maternal-zygotic mutant and
control littermate late blastocysts with antibodies to Oct4,
which marks the entire ICM [18, 19], as well as Nanog, which
marks the epiblast, and Gata6, which marks the primitive
endoderm [20]. All three markers were normally distributed in
littermate controls but were entirely absent from all cells in
maternal-zygotic mutant embryos (Figures 4G and 4H). We
also allowed maternal-zygotic and littermate blastocysts to
develop for another 6 days in standard embryonic stem cell
(ESC) conditions and found that, while littermates formed
normal-looking ESC outgrowths atop a layer of trophoblast
giant cells, maternal-zygotic mutants generated only a tropho-
blast layer (Figure 4I). When blastocysts were outgrown in 2i
conditions [21] followed by passaging to derive stable ESC
lines, only lines corresponding to the zygotically heterozygous
littermate genotype could be obtained (Figure 4J). Finally, to
confirm that the lack of ICM or its derivative lineages in
maternal-zygotic mutants is lethal in vivo, we performed
crosses between Nf2flox/flox;Zp3-CreCre/+ females and Nf2del/+
males and genotyped resulting embryos at E6.5. While
morphologically normal littermates were obtained at the ex-
pected frequency, no intact maternal-zygotic mutants could
be recovered apart from two small, partially resorbed cell
masses (Figure 4K). These embryos are thus highly reminis-
cent of other mutants that fail to specify a pluripotent
ICM [18, 22, 23], indicating that formation of excess TE in
maternal-zygotic Nf2mutants occurs at the expense of normal
ICM development.
Here, we have identified a role for Nf2 upstream of Hippo
signaling in segregating the ICM from the TEduringmousepre-
implantation development. We show that Nf2 is required for
Lats1/2-dependent Yap phosphorylation in inside cells of the
embryo. Furthermore, a combination of maternal and zygotic
Nf2 is present during preimplantation development, and both
of these pools must be removed to entirely misregulate Yap
localization. In these maternal-zygotic mutants, inside cells
adopt a broadly TE-like developmental program and fail to
generate the ICM or its derivative lineages, resulting in peri-
implantation lethality. This demonstrates for the first time
that the activation of Hippo signaling in inside cells of the pre-
implantation embryo is absolutely required for the formation
of a fully functional ICM and that, in its absence, all cells will
revert to a TE fate, regardless of their position in the embryo.
The exact molecular mechanism by which Nf2 participates
in Hippo signaling in inside cells of the embryo remains to
be elucidated, but several lines of evidence suggest that
adherens junctions (AJs) may be involved. Embryos deficient
in both maternal and zygotic E-cadherin have mislocalized
Yap and ectopic Cdx2 expression in their inside cells, indi-
cating a defect in Hippo signaling [24], and the AJ component
a-catenin, which participates in Hippo signaling in the mam-
malian epidermis [5, 25], can interact directly with Nf2 [26].
Additionally, other work by Hirate et al. published in this issue
of Current Biology demonstrates that Nf2 can facilitate an(I) Representative images of m2z2Nf2 and m2z+Nf2 outgrowths after 6 days
(J) Numbers and genotypes of ESC lines derived from m2z2Nf2 and m2z+Nf
(K) Numbers of m2z2Nf2 and m2z+Nf2 embryos recovered from deciduae
resorption (indicated by A) that was m2z2Nf2, two resorptions (indicated by B
Dashed lines indicate inside cells. See also Figure S3.interaction between the AJ component E-cadherin and angio-
motin (Amot), another component required for Hippo signaling
in inside cells of the preimplantation embryo [27]. Together,
these data suggest that a complex containing AJ components,
Nf2, and Amot forms in inside cells to facilitate the phosphor-
ylation of Yap.
Our observation that Nf2 overexpression alone is insufficient
to alter Yap localization in outside cells suggests that some
other component or components required for active Hippo
signaling may be absent or actively blocked in these cells.
The apical localization of Lats1/2 may represent one such
mechanism preventing active Hippo signaling in outside cells.
Interestingly, Amot also localizes to the apical domain of
polarized embryos [27]. Such localization may serve to physi-
cally sequester Lats1/2 and Amot away from an AJ-Hippo
signaling complex or may bring them into proximity with
some additional pathway inhibitor or inhibitors. Further work
will be required to identify the factors responsible for this
localization and to understand its specific consequences for
Hippo signaling in outside cells of the preimplantation embryo.
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